Coherus Oncology
CHRS
CHRS
169 hedge funds and large institutions have $348M invested in Coherus Oncology in 2023 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 63 increasing their positions, 48 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
5% more funds holding
Funds holding: 161 → 169 (+8)
6% less capital invested
Capital invested by funds: $371M → $348M (-$23.5M)
7.13% less ownership
Funds ownership: 91.91% → 84.78% (-7.1%)
Holders
169
Holding in Top 10
2
Calls
$2.35M
Puts
$1.74M
Top Buyers
| 1 | +$23.3M | |
| 2 | +$8.61M | |
| 3 | +$4.88M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.49M |
| 5 |
Rafferty Asset Management
New York
|
+$3.28M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$12.4M | |
| 3 | -$3.56M | |
| 4 |
Millennium Management
New York
|
-$2.38M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$1.62M |